Medigen Biotechnology Corp. (3176.TWO)
TWD 28.75
(-9.87%)
TWD 28.75
(-9.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -561.29 Million TWD | 16.95% |
| 2022 | -675.87 Million TWD | -1184.59% |
| 2021 | -52.61 Million TWD | 84.43% |
| 2020 | -337.92 Million TWD | -32.15% |
| 2019 | -255.71 Million TWD | 42.23% |
| 2018 | -442.66 Million TWD | 5.16% |
| 2017 | -466.75 Million TWD | 17.87% |
| 2016 | -568.3 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 11.94 Million TWD | 115.77% |
| 2024 Q1 | -75.74 Million TWD | 76.49% |
| 2023 Q3 | -47.1 Million TWD | 51.6% |
| 2023 FY | -561.29 Million TWD | 16.95% |
| 2023 Q1 | -94.69 Million TWD | 73.34% |
| 2023 Q4 | -322.16 Million TWD | -583.88% |
| 2023 Q2 | -97.33 Million TWD | -2.79% |
| 2022 Q1 | -81.7 Million TWD | -205.93% |
| 2022 FY | -675.87 Million TWD | -1184.59% |
| 2022 Q4 | -355.2 Million TWD | -205.69% |
| 2022 Q3 | -116.19 Million TWD | 5.36% |
| 2022 Q2 | -122.77 Million TWD | -50.26% |
| 2021 Q3 | 63.6 Million TWD | 0.0% |
| 2021 FY | -52.61 Million TWD | 84.43% |
| 2021 Q4 | 77.13 Million TWD | 21.26% |
| 2020 FY | -337.92 Million TWD | -32.15% |
| 2019 FY | -255.71 Million TWD | 42.23% |
| 2018 FY | -442.66 Million TWD | 5.16% |
| 2017 FY | -466.75 Million TWD | 17.87% |
| 2016 FY | -568.3 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -983.96% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 323.612% |
| Level Biotechnology Inc. | 62.9 Million TWD | 992.292% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -919.815% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -768.274% |
| TaiMed Biologics Inc. | -194.81 Million TWD | -188.125% |
| GlycoNex Incorporation | -178.36 Million TWD | -214.695% |
| VBI | -6.6 Million TWD | -8403.196% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | -237.581% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -5154.597% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -1370.439% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | -233.974% |
| Visgeneer Inc. | -19.58 Million TWD | -2765.363% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 17.801% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 189.706% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 875.271% |
| Neith Corporation | -40.03 Million TWD | -1302.083% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 51.606% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -9182.223% |
| Enimmune corporation | -223.74 Million TWD | -150.866% |
| TaiRx, Inc. | -212.29 Million TWD | -164.398% |
| CHO Pharma, Inc. | -306.08 Million TWD | -83.378% |
| EirGenix Inc. | -915.2 Million TWD | 38.67% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 1228.392% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -786.443% |
| Lin BioScience, Inc. | -687.19 Million TWD | 18.32% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | -259.057% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 2562.689% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -665.908% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -1085.344% |
| RBC Bioscience Corporation | 6.43 Million TWD | 8829.331% |
| BiOptic Inc. | 37.74 Million TWD | 1586.995% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 18.419% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -1410.281% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -812.083% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 304.236% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -509.376% |
| NaviFUS Corp. | -65.72 Million TWD | -753.955% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -537.192% |
| Sinew Pharma Inc. | -170.92 Million TWD | -228.395% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -723.51% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 529.572% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | -135.798% |
| AP Biosciences Inc | -339.29 Million TWD | -65.43% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -868.57% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 6737.843% |
| Intech Biopharm Corporation | -337.98 Million TWD | -66.07% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 57.247% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -987.509% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | -228.853% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 204.06% |
| TCI GENE Inc. | 11.67 Million TWD | 4908.498% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -340.066% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | -89.431% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | -158.053% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 5646.403% |
| PharmaEngine, Inc. | 274.65 Million TWD | 304.368% |
| Savior Lifetec Corporation | 30.03 Million TWD | 1969.118% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 510.511% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 46.363% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | -347.797% |
| Acepodia, Inc. | -817.31 Million TWD | 31.325% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | -14.913% |